Corporate Partner Program

The COPD Foundation’s Corporate Partner Program was established in 2015 as a way for us to interact with external organizations on our shared goals of undertaking initiatives within the respiratory space relating to chronic obstructive pulmonary disease (COPD), bronchiectasis and nontuberculous mycobacterium (NTM) lung disease. The Corporate Partner Program gives the Foundation greater financial flexibility to take on critical mission-based work and support the greater respiratory community.


The COPD Foundation welcomes the support of corporate sponsors who seek to improve the lives of those affected by COPD. Members of the program are able to engage with the Foundation and its programs at various levels to enhance its efforts in research, advocacy, care delivery, and community development. To join, potential sponsors must demonstrate a commitment to the patient/caregiver community and the Foundation’s mission, principles, public positions, policies and standards.

Corporate relationships must follow a number of basic requirements. While the COPD Foundation accepts financial support and other benefits from corporations, the COPD Foundation will always exercise independent judgment in all its decision-making.

For more information about the COPD Foundation Corporate Partner Program please contact Kip Adams at kadams@COPDFoundation.org.

The COPD Foundation thanks the organizations below for their continued support.

Chairman Level

GSK
Grifols
Sunovion
Boehringer Ingelheim
Mylan
Pfizer
AstraZeneca

President Level

Insmed
Theravance Biopharma

Director Level

Verona Pharma

Supporter Level

Pulmonx
SmartVest - Electromed
new diagnostic design
Hill-Rom
Vapotherm
Takeda
Olympus
Circassia